N-001 was designed by a startup to counter pain but avoid the detrimental side effects of opioid use, addiction among them

To enter the downtown San Francisco lab space that houses their Nebraska-born biotech startup company, Neurocarrus, Paul Blum and Benjamin Pavlik often pass a collection of people who Blum described as “falling apart from overdose”. The lab is located below a methadone clinic.

“We see the effects of drug addiction and mental illness every single day,” said Arvind Gupta, the founder of IndieBio, an incubator which has invested $250,000 in seed funding and lab space for Neurocarrus because he believes the co-founders might offer a partial solution to a national crisis.

Continue reading…

Read More Treating pain without addiction: inside the lab fighting the opioid crisis

Facebook Comments